Board Meeting5 Aug 2026, 05:50 pm
Chandra Bhagat Pharma to increase authorized capital, issue warrants
AI Summary
Chandra Bhagat Pharma Limited announced board meeting outcomes including approval to increase authorized share capital from ₹8.5 Cr to ₹15 Cr. The company also plans to issue up to 66,00,000 convertible warrants to promoters and non-promoters at ₹44 each, subject to shareholder approval. The board also approved the Directors' Report for FY26 and the notice for the Annual General Meeting scheduled for September 1, 2026. An independent scrutinizer will be appointed for the AGM.
Key Highlights
- Authorized share capital to increase from ₹8.5 Cr to ₹15 Cr.
- Plan to issue 66,00,000 convertible warrants at ₹44 each.
- Warrants to be issued on preferential basis to promoters and non-promoters.
- AGM scheduled for September 1, 2026, to seek shareholder approval.
- Directors' Report for FY26 approved.
Price Impact
More from CBPL